Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ANPEP | P15144 | 1/20 | 0.69 |
| ▸ | ENPEP | Q07075 | 1/20 | 0.69 |
| ▸ | FOLH1 | Q04609 | 8/20 | 0.59 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.57 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.57 |
| ▸ | MAOA | P21397 | 1/20 | 0.57 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.57 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.57 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.57 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.57 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.57 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.57 |
| ▸ | SLC7A5 | Q01650 | 2/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9622159 | 1.00 | ANPEP (0.69) | ANPEPENPEPFOLH1SLC6A2TAAR1 | |
| SCHEMBL14478232 | 1.00 | ANPEP (0.69) | ANPEPENPEPFOLH1SLC6A2TAAR1 | |
| Hydrochloric Acid SCHEMBL27656347 | 0.98 | ANPEP (0.67) | ANPEPENPEPFOLH1SLC6A2TAAR1 | |
| Isophthalic Acid SCHEMBL28055755 | 0.91 | SLC6A2 (0.66) | ANPEPENPEPFOLH1SLC6A2TAAR1 | |
| Trifluoroacetamide SCHEMBL9181331 | 0.89 | ANPEP (0.57) | ANPEPENPEPFOLH1SLC6A2TAAR1 | |
| SCHEMBL765921 | 0.87 | FOLH1 (0.61) | ANPEPENPEPFOLH1 | |
| Amphetamine SCHEMBL21464672 | 0.87 | TAAR1 (0.70) | ANPEPENPEPSLC6A2TAAR1MAOA | |
| Amphetamine SCHEMBL29185448 | 0.87 | TAAR1 (0.70) | ANPEPENPEPSLC6A2TAAR1MAOA | |
| Glutamic Acid SCHEMBL1033856 | 0.86 | FOLH1 (0.53) | ANPEPENPEPFOLH1SLC7A5 | |
| SCHEMBL6105481 | 0.86 | ANPEP (0.55) | ANPEPENPEPSLC6A2TAAR1MAOA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 120 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250332223-A1 | GHRH ANTAGONISTS FOR USE IN A METHOD OF TREATING SARCOIDOSIS | UNIV MIAMI (US) | 2025-10-30 | — | — | US | claimed |
| US-12377135-B2 | GHRH antagonists for use in a method of treating sarcoidosis | UNIVERSITY OF MIAMI (US) | 2025-08-05 | — | — | US | claimed |
| EP-4331674-A2 | GHRH ANTAGONISTS FOR USE IN A METHOD OF TREATING SARCOIDOSIS | University of Miami (US) | 2024-03-06 | — | — | EP | claimed |
| EP-3999095-B1 | GHRH ANTAGONISTS FOR USE IN A METHOD OF TREATING SARCOIDOSIS | UNIV MIAMI (US) | 2023-09-13 | — | — | EP | claimed |
| EP-3999095-A1 | GHRH ANTAGONISTS FOR USE IN A METHOD OF TREATING SARCOIDOSIS | University of Miami (US) | 2022-05-25 | — | — | EP | claimed |
| US-20220143149-A1 | GHRH ANTAGONISTS FOR USE IN A METHOD OF TREATING SARCOIDOSIS | THE UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS | 2022-05-12 | — | — | US | claimed |
| WO-2021011874-A1 | GHRH ANTAGONISTS FOR USE IN A METHOD OF TREATING SARCOIDOSIS | UNIVERSITY OF MIAMI (US) | 2021-01-21 | — | — | WO | claimed |
| US-20200276273-A1 | METHOD FOR TREATING MYELOID LEUKEMIA | THE UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS | 2020-09-03 | — | — | US | claimed |
| WO-2019060601-A1 | METHOD FOR TREATING MYELOID LEUKEMIA | UNIVERSITY OF MIAMI (US) | 2019-03-28 | — | — | WO | claimed |
| CN-102977212-A | Compositions comprising anti-IGF-1r antibodies and methods for their production | AMGEN INC | 2013-03-20 | — | — | CN | claimed |
| US-20250332223-A1 | GHRH ANTAGONISTS FOR USE IN A METHOD OF TREATING SARCOIDOSIS | UNIV MIAMI (US) | 2025-10-30 | — | — | US | disclosed |
| US-12377135-B2 | GHRH antagonists for use in a method of treating sarcoidosis | UNIVERSITY OF MIAMI (US) | 2025-08-05 | — | — | US | disclosed |
| EP-4331674-A2 | GHRH ANTAGONISTS FOR USE IN A METHOD OF TREATING SARCOIDOSIS | University of Miami (US) | 2024-03-06 | — | — | EP | disclosed |
| EP-3999095-B1 | GHRH ANTAGONISTS FOR USE IN A METHOD OF TREATING SARCOIDOSIS | UNIV MIAMI (US) | 2023-09-13 | — | — | EP | disclosed |
| EP-3999095-A1 | GHRH ANTAGONISTS FOR USE IN A METHOD OF TREATING SARCOIDOSIS | University of Miami (US) | 2022-05-25 | — | — | EP | disclosed |
| US-4369037-A | Hair treatment cosmetics containing cationic keratin derivatives | KAO SOAP CO., LTD. (JP) | 1983-01-18 | — | — | US | disclosed |
| US-4364926-A | INHIBITORS OF TRANSFERASES; ALKALI RESISTANCE; HEAT RESISTANCE; DENTIFRICES | DAINIPPON PHARMACEUTICAL CO., LTD. (JP) | 1982-12-21 | — | — | US | disclosed |
| US-4314999-A | N-Acyl derivatives of glucosamine having antitumor chemotherapeutic acitivity | PROTER S.P.A. (IT) | 1982-02-09 | — | — | US | disclosed |
| US-4294856-A | Process for manufacture of artificial milk replacer for raising infant pigs and other infant animals | Tokai Regional Fisheries Research Laboratory (JP) | 1981-10-13 | — | — | US | disclosed |
| US-3948875-A | Process for the preparation of epidermal growth factor and new derivative using cross-linked polyacrylamide gel at a pH of 1-3 | COHEN STANLEY | 1976-04-06 | — | — | US | disclosed |